Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
InterContinental Hotels
IHG
$23.5B
| $2.14M | ﹤0.01% |
36,543
-79,561
| -69% | -$4.58M |
|
|
AOI
2227
DELISTED
Alliance One International
AOI
| $2.13M | ﹤0.01% |
148,180
-14,300
| -9% | -$183K |
|
|
ASRT
2228
DELISTED
Assertio
ASRT
| $2.13M | ﹤0.01% |
3,307
-334
| -9% | -$223K |
|
|
QTRH
2229
DELISTED
Quarterhill Inc. Common Shares
QTRH
| $2.13M | ﹤0.01% |
+1,477,003
| New | +$2.13M |
|
2230
Boot Barn
BOOT
$4.94B
| $2.12M | ﹤0.01% |
299,700
+277,900
| +1,275% | +$2.4M |
|
2231
NETSCOUT
NTCT
$2.88B
| $2.12M | ﹤0.01% |
+61,700
| New | +$2.23M |
|
2232
Greif Class B
GEF.B
$4.18B
| $2.12M | ﹤0.01% |
35,100
-9,500
| -21% | -$603K |
|
2233
Altimmune
ALT
$564M
| $2.12M | ﹤0.01% |
22,074
+6,104
| +38% | +$1.01M |
|
|
NP
2234
DELISTED
Neenah, Inc. Common Stock
NP
| $2.12M | ﹤0.01% |
26,400
-38,600
| -59% | -$3M |
|
|
BECN
2235
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $2.12M | ﹤0.01% |
43,157
-109,200
| -72% | -$5.37M |
|
|
ANDV
2236
DELISTED
Andeavor
ANDV
| $2.11M | ﹤0.01% |
+22,585
| New | +$1.91M |
|
|
GWR
2237
DELISTED
Genesee & Wyoming Inc.
GWR
| $2.11M | ﹤0.01% |
+30,850
| New | +$2.04M |
|
|
TNH
2238
DELISTED
Terra Nitrogen
TNH
| $2.11M | ﹤0.01% |
24,542
+15,442
| +170% | +$1.36M |
|
2239
VanEck Semiconductor ETF
SMH
$71.9B
| $2.1M | ﹤0.01% |
+51,400
| New | +$2.12M |
|
2240
Southern First Bancshares
SFST
$610M
| $2.1M | ﹤0.01% |
56,700
+16,081
| +40% | +$552K |
|
|
HIFR
2241
DELISTED
InfraREIT, Inc.
HIFR
| $2.1M | ﹤0.01% |
+109,400
| New | +$2.08M |
|
2242
Radcom
RDCM
$171M
| $2.09M | ﹤0.01% |
108,100
-20,300
| -16% | -$397K |
|
2243
ArcBest
ARCB
$3.21B
| $2.08M | ﹤0.01% |
101,135
-293,700
| -74% | -$6.37M |
|
|
FSB
2244
DELISTED
Franklin Financial Network, Inc.
FSB
| $2.08M | ﹤0.01% |
50,399
-29,601
| -37% | -$1.19M |
|
|
OAKS
2245
DELISTED
Five Oaks Investment Corp.
OAKS
| $2.08M | ﹤0.01% |
426,109
+75,327
| +21% | +$396K |
|
2246
China Automotive Systems
CAAS
$141M
| $2.08M | ﹤0.01% |
428,933
-38,500
| -8% | -$187K |
|
2247
Franklin Covey
FC
$223M
| $2.07M | ﹤0.01% |
107,200
+300
| +0.3% | +$6.19K |
|
|
PPBI
2248
DELISTED
Pacific Premier Bancorp
PPBI
| $2.07M | ﹤0.01% |
56,008
-68,292
| -55% | -$2.46M |
|
2249
Ark Restaurants
ARKR
$20.2M
| $2.06M | ﹤0.01% |
85,000
+3,000
| +4% | +$75.5K |
|
|
AGTC
2250
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.06M | ﹤0.01% |
403,184
+151,171
| +60% | +$849K |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.